Impact of mass vaccination with polysaccharide conjugate vaccine against serogroup C meningococcal disease in Spain

By Salleras L.   Domnguez A.   Cardenosa N.  

Vaccine, Vol. 21, Iss. 7, 2003-01 ,pp. : 725-728

Elsevier

Access to resources Recommend Favorite

Economic analysis of the 1992-1993 mass immunization campaign against serogroup C meningococcal disease in Quebec

By De Wals P.   Erickson L.  

Vaccine, Vol. 20, Iss. 21, 2002-06 ,pp. : 2840-2844

Elsevier

Access to resources Recommend Favorite

The effectiveness of serogroup C meningococcal vaccine estimated from routine surveillance data

By Rivest P.   Allard R.  

Vaccine, Vol. 20, Iss. 19, 2002-06 ,pp. : 2533-2536

Elsevier

Access to resources Recommend Favorite

An outbreak of serogroup C meningococcal disease in the province of Antwerp (Belgium) in 2001–2002

By de Schrijver K.   Maes I.  

European Journal of Epidemiology, Vol. 18, Iss. 11, 2003-11 ,pp. : 1073-1077

Springer Publishing Company

Access to resources Recommend Favorite

Seroprevalence of meningococcal serogroup C bactericidal antibody in England and Wales in the pre-vaccination era

By Trotter C.   Borrow R.   Andrews N.   Miller E.  

Vaccine, Vol. 21, Iss. 11, 2003-03 ,pp. : 1094-1098

Elsevier

Access to resources Recommend Favorite